Cooperation Agreement for Palm Oil Research and Development

Aug.29.2023
Cooperation Agreement for Palm Oil Research and Development
Huabao shares announce research collaboration with Malaysian Palm Oil Board and Bunge Loders Croklaan for palm oil-related projects.

Recently, Huabao Group announced on its official website that it has signed a three-party research project cooperation agreement with Malaysian Palm Oil Board's wholly-owned subsidiary, Malaysian Palm Oil Technology Development (Shanghai) Co., Ltd., and Bangi Gordess (Xiamen) Oil and Fat Technology Co., Ltd. The collaboration aims to conduct related technical research and product development using palm oil as the raw material.


PORTSIM, a subsidiary of the Malaysian Palm Oil Board (MPOB), is a branch located in Shanghai, China. Established in 2005, PORTSIM aims to develop, expand, and promote the Malaysian palm oil market in China, while providing technical support and consultancy services to relevant companies. MPOB, a statutory body under the Malaysian government, is primarily responsible for promoting and formulating national goals, policies, and priorities in the palm oil industry in Malaysia.


Bunge Loders Croklaan is a sustainable specialty plant oils and fats producer and supplier in the food manufacturing industry. The company operates the global B2B edible oil business under the brand Bunge (NYSE: BG). Its products are widely used in baking, confectionery, cooking, and infant nutrition.


According to reports, the palm oil industry serves as a foundation of Malaysia's economy, making it the world's second largest palm oil producer after Indonesia. The two countries collectively account for over 80% of global palm oil production, with China emerging as the largest palm oil importing nation worldwide. Palm oil and its derivatives find wide applications in various sectors including food, non-food, and animal feed industries. Due to its extensive usage and high volumes of production, the oil palm crop offers promising investment returns in terms of scientific research and technological advancements.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Special Report | The Global Flavor Shift: How Changing Tastes Are Driving Nicotine Product Innovation
Special Report | The Global Flavor Shift: How Changing Tastes Are Driving Nicotine Product Innovation
The global nicotine industry is undergoing a profound transformation driven by shifting consumer tastes and evolving regulations. From shisha to nicotine pouches, flavor innovation is creating new opportunities across different product segments, redefining consumer preferences and shaping the future of nicotine worldwide.
Jul.09
BAT launches two glo HYPER “neo” sticks in South Korea, highlighting tropical flavors
BAT launches two glo HYPER “neo” sticks in South Korea, highlighting tropical flavors
BAT’s heated tobacco brand glo has launched two new products in the HYPER series “neo” sticks — “Island Click” and “Blush Click.”
Aug.18 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
2Firsts Exclusive Interview | JTI Launches New-Generation Ploom AURA, Focuses on Enhanced Flavor and Customization
2Firsts Exclusive Interview | JTI Launches New-Generation Ploom AURA, Focuses on Enhanced Flavor and Customization
2Firsts interviewed Nick Geens, JTI’s Vice President of Reduced-Risk Products, to discuss the new-generation heated tobacco product Ploom AURA, launched in Japan in May 2025, highlighting enhanced flavor, customizable heating modes, harm reduction concept, and future market plans.
Jul.16
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
WHO Criticized for Questioning FDA’s Harm Reduction Assessment, Accused of Defying Scientific Consensus
A World Health Organization (WHO) official, Dr. Roa, recently questioned the U.S. Food and Drug Administration’s (FDA) scientific assessment of e-cigarettes and nicotine pouches, claiming there was no independent consensus and suggesting its conclusions may have been influenced by the industry. Her remarks contradict the consensus of leading international scientific bodies and are seen as a direct challenge to FDA’s credibility and to the integrity of public health science.
Aug.20 by 2FIRSTS.ai
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.
Jul.29 by 2FIRSTS.ai